Concepedia

Birgit Bollbuck

BB

Statistics

Publications

11

Citations

1.1K

H-Index

11

Active since

1996

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of California San Diego

Scripps Research Institute

Birgit Bollbuck is an author at Novartis (Switzerland) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1996–2021

11

Publications

11

A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells

Paraskevi Giannakakou, Rick Gussio, Eva Nogales et al. · Proceedings of the National Academy of Sciences · 2000 · 477 citations

, , +15

Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK

Rudolf Waelchli, Birgit Bollbuck, Christian Bruns et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 148 citations · Full text

, , +8

Chemical synthesis and biological properties of pyridine epothilones

K. C. Nicolaou, Rita Scarpelli, Birgit Bollbuck et al. · Chemistry & Biology · 2000 · 144 citations · Full text

, , +7

A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis

Jean Quancard, Birgit Bollbuck, Philipp Janser et al. · Chemistry & Biology · 2012 · 128 citations

, , +10

Total Synthesis of 16-Desmethylepothilone B, Epothilone B10, Epothilone F, and Related Side Chain Modified Epothilone B Analogues

K. C. Nicolaou, David Hepworth, N. Paul King et al. · Chemistry - A European Journal · 2000 · 52 citations · Full text

, , +10

1–5 of 11